{
    "organizations": [],
    "uuid": "c65f06053444bac2a5e926b51b7d8164de42f1bd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-akcea-announces-expansion-of-globa/brief-akcea-announces-expansion-of-global-early-access-program-to-provide-volanesorsen-to-people-living-with-fcs-idUSFWN1S90NT",
    "ord_in_thread": 0,
    "title": "BRIEF-Akcea Announces Expansion of Global Early Access Program to Provide Volanesorsen to People Living with FCS",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - Akcea Therapeutics Inc:\n* AKCEA THERAPEUTICS - EXPANDED GLOBAL EARLY ACCESS PROGRAM TO U.S. TO PROVIDE VOLANESORSEN TO PEOPLE LIVING WITH FAMILIAL CHYLOMICRONEMIA SYNDROME (FCS) Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-02T19:20:00.000+03:00",
    "crawled": "2018-05-03T11:49:39.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "akcea",
        "therapeutic",
        "inc",
        "akcea",
        "therapeutic",
        "expanded",
        "global",
        "early",
        "access",
        "program",
        "provide",
        "volanesorsen",
        "people",
        "living",
        "familial",
        "chylomicronemia",
        "syndrome",
        "fcs",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}